Broad Institute: Messenger RNAs With Multiple "tails" Could Lead to More Effective Therapeutics
March 23, 2024
March 23, 2024
CAMBRIDGE, Massachusetts, March 23 (TNSres) -- The Broad Institute issued the following news on March 22, 2024:
Messenger RNA (mRNA) made its big leap into the public limelight during the pandemic, thanks to its cornerstone role in several COVID-19 vaccines. But mRNAs, which are genetic sequences that instruct the body to produce proteins, are also being developed as a new class of drugs. For mRNAs to have broad therapeutic uses, however, the molecules will need to last longer in th . . .
Messenger RNA (mRNA) made its big leap into the public limelight during the pandemic, thanks to its cornerstone role in several COVID-19 vaccines. But mRNAs, which are genetic sequences that instruct the body to produce proteins, are also being developed as a new class of drugs. For mRNAs to have broad therapeutic uses, however, the molecules will need to last longer in th . . .